Clinical Trials · NCT07029009
Liraglutide Treatment in Patients With Maturity-onset Diabetes of the Young (MODY)
- Phase
- Phase 2
- Recruitment status
- Recruiting
- Sponsor
- Mansa
- Enrollment
- 50
- Start date
- May 2025
- Locations
- 1 site, United States
- Primary endpoint
- Blood sugar control - HbA1C